全部

1·Medicare could save hundreds of millions of dollars a year if everyone used the cheaper drug, Avastin, instead of the costlier one, Lucentis.

如果每个人都使用更便宜的药物安维汀，而不是更昂贵的雷珠单抗，那么医疗保障每年就可以节省数亿美元。

2·The Food and Drug Administration has not approved Avastin for use in the eye, and using it rather than the alternative, Lucentis, might carry an additional, although slight, safety risk.

美国食品和药品管理局还没有批准阿瓦斯汀用于眼部治疗，使用它来代替雷珠单抗可能会产生额外的安全风险，尽管这一风险也许很轻微。

3·The FDA is also concerned that Avastin has bad side effects.

FDA也注意到阿伐斯汀有坏的副作用。

4·The data also suggest that Avastin is potentially more toxic than chemotherapy.

数据还表明，相比化疗，阿伐斯汀具有更多的潜在毒性。

5·About 2% of women in the study on chemo plus Avastin died, whereas no one who got chemotherapy alone did.

研究中大约2 %左右的妇女接受化疗和阿伐斯汀联用治疗时死了，但没有一个人单接受化疗而死亡。

6·Some doctors on their own already use Avastin to treat breast cancer, in a so-called off-label use of the drug. But F.

有些医生已经以一种所谓超出该药药物说明书列出的应用范围方式将这种药应用到乳腺癌治疗。

7·Now that the FDA has formally withdrawn the breast cancer indication for Avastin, still more debate is likely to break out.

现在，美国食品和药物管理局正式撤销安维汀治疗的乳腺癌适应症，更多的争论很可能会爆发。

8·The median survival for patients taking both Avastin and Gemzar was 5.7 months compared with 6.0 months for patients taking Gemzar alone.

吉西他滨合用贝伐单抗的患者中位生存期为5.7个月，而单用吉西他滨者为6个月。

9·The study researchers assigned 302 patients to receive Avastin and Gemzar and assigned an additional 300 patients to receive Gemzar plus placebo.

该研究中，302名患者接受吉西他滨合用贝伐单抗，300名患者接受吉西他滨和安慰剂。

10·Late last month, federal drug regulators gave their answer when they approved a drug called Avastin for treatment of patients with advanced breast cancer.

上个月底，联邦药品监管机构给予他们的答案时，他们批准了一项所谓的药物阿瓦斯丁用于治疗晚期乳腺癌。